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Incidence of Invasive Cancers following Basal Cell Skin Cancer
Fabio Levi,12 Carlo La Vecchia,3 Van-Cong Te,1 Lalao Randimbison,1 and Georges Erler2
To obtain quantitative information on the risk of invasive cancers following a diagnosis of basal cell
carcinoma (BCC) of the skin, patients with incident BCC cases listed in the cancer registries of the Swiss
cantons of Vaud and Neuchatel between 1974 and 1994 were actively followed up through December 31,
1994, for the occurrence of subsequent invasive neoplasms. Among 11,878 persons with incident BCC who
were followed for a total of 76,510 person-years at risk, 1,543 metachronous cancers were observed versus
1,397.9 expected, corresponding to a standardized incidence ratio (SIR) of 1.1 (95% confidence interval (Cl)
1.0-1.2). However, after exclusion of skin cancers (mostly squamous cell carcinoma and melanoma), 975
second primary cancers were observed versus 1,059 expected (SIR = 0.9, 95% Cl 0.8-1.0). Significant
excesses were registered for cancer of the lip (SIR = 2.2), for squamous cell skin cancer (SIR = 4.5) and
melanoma of the skin (SIR = 2.5), and for non-Hodgkin's lymphoma (SIR = 1.9). The SIRs were also above
unity, though not significantly, for cancers of the salivary glands (SIR = 2.8) and the small intestine (SIR = 2.1)
and for soft-tissue sarcomas (SIR = 1.7). The SIR for lung cancer was 0.9. The SIRs for salivary gland and skin
cancer were appreciably greater below age 70 years. For most sites, particularly for squamous cell cancer and
melanoma of the skin, the SIRs remained elevated 5 or more years after BCC diagnosis. The cumulative
incidence of squamous cell skin cancer was 13% at 19 years; this stresses the importance of carefully
monitoring skin lesions among persons previously diagnosed with BCC. Am J Epidemiol 1998;147:722-6.
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Basal cell carcinoma (BCC) is the most common
type of skin cancer (1-4). Because of the advanced
age at which most cases occur, and because of its
favorable prognosis, underregistration is frequent. The
cancer registries of the French-speaking Swiss cantons
of Vaud and Neuchatel are among the few cancer
registries that have paid specific attention to the issue
of skin cancer; in these regions, cutaneous lesions that
are surgically resected have traditionally been patho-
logically examined (1, 5).
We previously described an excess of non-
Hodgkin's lymphoma following a diagnosis of BCC
(1). However, an excess incidence of other neoplasms
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after a diagnosis of BCC has also been reported,
including cancers of the lip, salivary glands, larynx,
lung, breast, and kidney, in addition to the well-known
(but still inadequately quantified) excess of other types
of skin cancer (6-9).
To obtain further quantitative information on this
question, which has both pathogenic and public health
implications, we computed the incidence of second
primary cancers among almost 12,000 subjects regis-
tered by the Vaud and Neuchatel cancer registries who
were followed for a maximum of 20 years.
MATERIALS AND METHODS
Data for the present report were abstracted from the
Vaud and Neuchatel cancer registry files, which in-
clude all incident cases of malignant neoplasms diag-
nosed in these cantons (10, 11). According to the 1990
Swiss census (12), the populations of these areas num-
ber approximately 600,000 and 160,000, respectively.
In these cantons, cancer registration systems have
been in place since 1972, and population-based inci-
dence data have been available since 1974. The reg-
istries are tumor-based, and multiple primary malig-
nancies found in the same person are entered
separately. Most cases are registered repeatedly and
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from different institutions, which improves the com-
pleteness and accuracy of registration. The basic in-
formation available from the registries comprises so-
ciodemographic characteristics of the patient (age,
sex), the primary site and histologic type of the tumor
according to the International Classification of Dis-
eases, Ninth Revision (13), and the date of diagnostic
confirmation (histologic or clinical diagnosis).
Both passive follow-up (through computer linkage
with official mortality data files) and active follow-up
(through verification of the vital status of apparently
nondeceased cases using registries of current resi-
dence) are conducted, and each subsequent item of
information concerning an already registered case is
used to complete the record of that patient.
After exclusion of synchronous cancers (n = 61),
the present series comprised a total of 11,878 histo-
logically confirmed BCCs of the skin (13) diagnosed
between 1974 and 1994. The age range was 15-100
years (median age, 68 years). These persons were
followed up to the end of 1994 for the occurrence of a
second primary neoplasm (excluding basal cell skin
carcinomas), emigration, or death.
Calculation of expected numbers of cases was based
on site-, sex-, age-, and calendar period-specific inci-
dence rates, multiplied by the corresponding number
of person-years at risk. The significance of the ob-
served : expected ratios (standardized incidence ratios
(SIRs)) and their corresponding 95 percent confidence
intervals was based on the Poisson distribution (14).
Cumulative incidence was computed using the stan-
dard life table approach (15).
RESULTS
Table 1 gives the distribution of the 11,878 cases of
BCC by age group, the corresponding incidence rates
for the entire calendar period, and the numbers of
person-years at risk in separate strata of time since
diagnosis, for a total of 76,510 person-years at risk.
Table 2 gives the observed and expected numbers of
all neoplasms and of cancers at selected sites. Overall,
1,543 metachronous cancers were observed versus
1,397.9 expected, corresponding to an SIR of 1.1 (95
percent confidence interval (Cl) 1.0-1.2). However,
after exclusion of skin cancers (mostly squamous cell
carcinoma and melanoma), 975 second primary can-
cers were observed versus 1,059.0 expected (SIR =
0.9, 95 percent CI 0.8-1.0). Significant excesses were
registered for cancer of the lip (9 observed, 4.1 ex-
pected; SIR = 2.2), for squamous cell skin cancer (501
observed, 111.7 expected; SIR = 4.5) and melanoma
of the skin (54 observed, 21.4 expected; SIR = 2.5),
for other skin cancers (13 observed, 4.7 expected;
SIR = 2.8), and for non-Hodgkin's lymphoma (43
observed, 22.5 expected; SIR = 1.9). The SIRs were
also above unity, though not significantly, for cancer
of the salivary glands (SIR = 2.8), the small intestine
(SIR = 2.1), and the breast (SIR = 1.2) and for
soft-tissue sarcoma (SIR = 1.7). The SIR was signif-
icantly below unity for cancer of the esophagus (11
observed, 24.4 expected; SIR = 0.5), stomach (26
observed, 56.2 expected; SIR = 0.5), and gallbladder
(8 observed, 16.7 expected; SIR = 0.5). The SIR was
0.9 (95 percent Cl 0.8-1.1) for cancer of the lung, 0.5
TABLE 1. Incidence of basal call carcinoma of the tUn, by age group and acoc Vaud and NeucMtel,
Switzerland, 1974-1994*
Age group (years)
<30
30-39
40-49
50-69
60-69
70-79
280
Total (all ages)
Time (years) since dagnosis
<1
1-4
5-9
210
Total
FMton-yeam
1 risk tor
•utnoquent
cancan
11,118
32,272
21,223
11,897
76,510
No. of a
Male*
44
161
472
1,036
1,650
1,724
860
5,947
net
Female*
59
223
598
902
1,348
1,572
1,229
5,931
Incidence rate
(par 100,000)
Moles
1.2
14.2
47.7
126.3
259.4
414.4
550.2
55.6t
Females
1.5
19.7
59.3
103.0
174.0
252.4
364.1
43.0+
* Denominators in 1980: vaud, 529,000; Neuchatel, 158,000. Denominators in 1990: vaud, 602,000;
Neuchatel, 164,000.
t Age-standardized to the world population.
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TABLE 2. Observed and expected numbers of second primary cancers aiI SetSOteO* SIISS aiiai an UDIMIdiagnosis of basal osfl carcinoma of ths skin, with corresponding standardized Incidence ratios: Vaud
and NeucMtal, Switzerland, 1974-1994
Ste
Up
Salivary glands
Mouth
Pharynx
Esophagus
Stomach
Small intestine
Colon
Rectum
Liver
Gallbladder
Pancreas
Larynx
Lung
Soft tissue
CO-9T
code(8)
140
142
141, 143, 144
145-148
150
151
152
153
164
155
156
157
161
162
171
Skin, squamous cell carcinoma 173
Skin, melanoma
Skin, other}:
Breast (females)
Uterine cervix
Corpus uteri
Ovary
Prostate
Bladder
Money
Brain and nerves
Thyroid
HodgJdn's disease
Other lymphoma
Myeloma
Leukemia
Total (afl sites)
Total (except skin)
172
173
174
180
182
183
185
188
189
191, 192
193
201
200,202
203
204-207
No. of <
Observed
9
5
7
18
11
26
6
103
47
20
8
28
7
128
6
501
54
13
126
7
23
17
155
51
18
3
7
2
43
10
19
1,543
975
asa*
Expected
4.1
1.8
10.2
17.9
24.4
56.2
2.9
103.7
62.1
18.6
16.7
38.4
13.2
139.1
3.6
111.7
21.4
4.7
108.5
11.0
23.4
17.3
•\42.2
48.6
23.7
9.1
6.8
3.1
22.5
13.4
28.1
1,397.9
1,059.0
StRt
Z 2
2.8
0.7
1.0
0.5
0.5
Z 1
1.0
0.8
1.1
0.5
0.7
0.5
0.9
1.7
4.5
2.5
2.8
1.2
0.6
1.0
1.0
1.1
1.1
0.8
0.3
1.0
0.6
1.9
0.8
0.7
1.1
0.9
95%
confidence
Interval
1.0-4.2
0.9-6.4
0.3-1.4
0.6-1.6
05-0.8
0.3-0.7
0.8-4.5
0.8-1.2
0.6-1.0
0.7-1.7
0.2-0.9
0.5-1.1
0.2-1.1
0.8-1.1
0.6-3.7
4.1-4.9
1.9-3.3
1.5-4.8
1.0-1.4
0.3-1.3
0.6-1.5
0.6-1.6
0.9-1.3
0.8-1.4
0.4-1.2
0.1-1.0
0.4-2.1
0.1-2.3
1.4-2.6
0.4-1.4
0.4-1.1
1.0-1.2
0.8-1.0
* Only one case each was observed for cancers of the bone (1.1 expected) and tests (2.3 expected); two
cases were observed for cancers of the nasal cavity (2.4 expected) and four for the eye (2.4 expected).
t ICD-9, International Oasafflcatkm of Diseases, Ninth Revision; SIR, standardized incidence ratio.
$ Four cases of sebaceous adenocardnoma, three cases of malignant carcinoid carcinoma, two cases of
rymphoepithelial carcinoma, one case of apocrine adenocardnoma, one case of Pagefs disease, one small ceD
carcinoma, and one "not otherwise specified" carcinoma were included.
(95 percent CI 0.2-1.1) for the larynx, and 0.6 (95
percent CI 0.3-1.3) for the uterine cervix.
Sites of second primary malignancies showing sig-
nificant excesses or meaningful patterns are consid-
ered further in table 3 by sex, age at BCC diagnosis,
and time since diagnosis. The elevated rates of skin
neoplasms and non-Hodgkin's lymphoma were similar
in males and females. The SIRs for cancers of the lip,
salivary glands, and skin were appreciably greater
below age 70 years. For most sites, particularly for
squamous cell cancer and melanoma of the skin, no
consistent pattern of trend was observed with time
since BCC diagnosis, and the SIRs remained signifi-
cantly above unity 5 or more years after BCC diagno-
sis. This indicates that the excess rates cannot be
simply explained in terms of increased surveillance
around and after BCC diagnosis.
Figure 1 shows the cumulative incidence of squa-
mous cell skin cancer following a diagnosis of BCC. A
steady increase was evident up to 19 years after BCC
diagnosis, reaching a cumulative incidence of 13 per-
cent.
DISCUSSION
The present study, based on more than 11,800 sub-
jects diagnosed with BCC and more than 76,000
person-years at risk, and on a population in which skin
lesions have long been pathologically examined, con-
firms that rates of various types of skin cancer, as well
as cancer of the lip and non-Hodgkin's lymphoma, are
significantly increased after a diagnosis of BCC.
Am J Epidemiol Vol. 147, No. 8, 1998
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FIGURE 1. Cumulative incidence (proportion) of squamous cell
skin carcinoma (n = 501) after initial diagnosis of basal cell skin
carcinoma (n = 11,878), by time Interval, In the cantons of Vaud and
Neuchatel, Switzerland, 1974-1994. (Data were obtained from the
Vaud and Neuchatel cancer registries.)
The excess incidence of squamous cell and melano-
matous skin cancers is probably due to a shared
predisposition—phenotypic characteristics and inher-
ited cancer susceptibility syndromes, such as nevoid
BCC syndrome—and risk factors, i.e., excess expo-
sure to sunshine and other sources of ultraviolet radi-
ation (16-18). This may explain, at least in part, the
excess incidence of non-Hodgkin's lymphoma as well,
assuming that ultraviolet radiation causes immunosup-
pression (1, 19). More difficult to interpret are the
appreciable excesses of salivary gland and skin
cancers in patients younger than 70 years. This may
reflect a predisposition to these neoplasms or a major
role of extensive exposure to selected risk factors at a
younger age (9).
The excess rate of sah'vary gland cancer is probably
real, since it has also been observed in other data
sets (20, 21), although the causes of salivary gland
cancer—apart from ionizing radiation—remain largely
undefined. The association has generally been attrib-
uted to the common embryologic origin of the salivary
glands and skin (both are derived from the ectodermal
layer of the fetus) (22).
A relation between tobacco use and squamous cell
skin cancer has been reported (21, 23). It is therefore
interesting to note the absence of an association, in this
data set, between BCC and subsequent lung cancer.
The lower rates of cancer of the esophagus, stomach,
larynx, uterine cervix, and mouth are also of interest.
They may reflect different social class correlates or
Am J Epidemiol Vol. 147, No. 8, 1998
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other general lifestyle factors related to these neo-
plasms, since in this population skin and breast cancer
tend to have favorable social class correlates, while
esophageal, larynx, gastric, and cervical cancer have
unfavorable ones (24). The SIR for breast cancer was
also moderately elevated in a Danish data set (19).
The absence of excess risk for all neoplasms except
skin cancer is also of interest, since a moderately
elevated SIR (1.15) was reported from a Danish study
(8). This may reflect different correlates of BCC risk
in various populations. In any case, there is no con-
vincing evidence of a generalized excess of nonskin
cancer following BCC.
In conclusion, this study, which was based on a
large data set and had a uniquely long period of
follow-up, confirms that subjects diagnosed with BCC
do not have a generalized excess risk of nonskin
neoplasms, with the exception of non-Hodgkin's lym-
phoma and cancers of the lip and salivary glands.
Given the small numbers of cases observed and the
relatively moderate excess risks, this finding cannot be
said to have prevention or screening implications, but
it may be of some interest in the diagnostic process for
these neoplasms. The excess rate of other skin cancers,
however, is large enough to suggest a need for careful
surveillance of skin lesions in BCC patients.
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